Fuling X. Zhou
169 Donghu Road
Wuhan, 430071, China
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 235 publications
A regional framework for defining and translating healthy dietary patterns in China.
Journal: NPJ science of food
Published: April 21, 2026
Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma.
Journal: Chinese medical journal
Published: January 12, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
[68Ga]Ga-Pentixafor PET/CT for Durie-Salmon PLUS staging and risk stratification in newly diagnosed multiple myeloma.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 23, 2025
Improving severity grading of chemotherapy-induced myelosuppression in AML via data-driven and model-based deep learning.
Journal: NPJ systems biology and applications
Published: November 13, 2025
Phase 1 Trial of BCL-2 Inhibitor Lisaftoclax (APG-2575) in Chinese Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Other Non-Hodgkin Lymphomas.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 10, 2025
Fertility preservation decision-making among adolescents and young adults with hematologic diseases and their families in China: a qualitative study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 01, 2025
LM-101, an Anti-SIRPα Antibody, in Patients with Relapsed/Refractory Lymphoma and Advanced Head and Neck Cancer: An Open-Label, Multicenter, Phase I Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 27, 2025
Tumor cell-specific loss of GPX4 reprograms triacylglycerol metabolism to escape ferroptosis and impair antitumor immunity in non-small cell lung cancer.
Journal: Protein & cell
Published: May 26, 2025
USP5 inhibition via bone marrow-targeted engineered exosomes for myeloproliferative neoplasms therapy.
Journal: Journal of nanobiotechnology
Published: April 18, 2025
Last Updated: 09/26/2026